Your browser doesn't support javascript.
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.
Fauver, Joseph R; Petrone, Mary E; Hodcroft, Emma B; Shioda, Kayoko; Ehrlich, Hanna Y; Watts, Alexander G; Vogels, Chantal B F; Brito, Anderson F; Alpert, Tara; Muyombwe, Anthony; Razeq, Jafar; Downing, Randy; Cheemarla, Nagarjuna R; Wyllie, Anne L; Kalinich, Chaney C; Ott, Isabel M; Quick, Joshua; Loman, Nicholas J; Neugebauer, Karla M; Greninger, Alexander L; Jerome, Keith R; Roychoudhury, Pavitra; Xie, Hong; Shrestha, Lasata; Huang, Meei-Li; Pitzer, Virginia E; Iwasaki, Akiko; Omer, Saad B; Khan, Kamran; Bogoch, Isaac I; Martinello, Richard A; Foxman, Ellen F; Landry, Marie L; Neher, Richard A; Ko, Albert I; Grubaugh, Nathan D.
  • Fauver JR; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA. Electronic address: joseph.fauver@yale.edu.
  • Petrone ME; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Hodcroft EB; Biozentrum, University of Basel, 4056 Basel, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Shioda K; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Ehrlich HY; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Watts AG; BlueDot, Toronto, ON M5J 1A7, Canada.
  • Vogels CBF; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Brito AF; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Alpert T; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510, USA.
  • Muyombwe A; Connecticut State Department of Public Health, Hartford, CT 06510, USA.
  • Razeq J; Connecticut State Department of Public Health, Hartford, CT 06510, USA.
  • Downing R; Connecticut State Department of Public Health, Hartford, CT 06510, USA.
  • Cheemarla NR; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
  • Wyllie AL; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Kalinich CC; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Ott IM; Department of Ecology & Evolutionary Biology, Yale University, New Haven, CT 06510, USA.
  • Quick J; Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
  • Loman NJ; Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
  • Neugebauer KM; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510, USA.
  • Greninger AL; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Jerome KR; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Roychoudhury P; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Xie H; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
  • Shrestha L; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
  • Huang ML; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Pitzer VE; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Iwasaki A; Department of Immunobiology, Yale University, New Haven, CT 06510, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Omer SB; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA; Yale Institute of Global Health, Yale University, New Haven, CT 06510, USA; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Yale School
  • Khan K; BlueDot, Toronto, ON M5J 1A7, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1A6, Canada; Section of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.
  • Bogoch II; Section of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.
  • Martinello RA; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Pediatrics, Yale School of Medicine, New Haven, CT 06510, USA; Department of Infection Prevention, Yale New Haven Health, New Haven, CT 06510, USA.
  • Foxman EF; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Immunobiology, Yale University, New Haven, CT 06510, USA.
  • Landry ML; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Clinical Virology Laboratory, Yale New Haven Health, New Haven, CT 06510, USA.
  • Neher RA; Biozentrum, University of Basel, 4056 Basel, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Ko AI; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
  • Grubaugh ND; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA. Electronic address: nathan.grubaugh@yale.edu.
Cell ; 181(5): 990-996.e5, 2020 05 28.
Artículo en Inglés | MEDLINE | ID: covidwho-60444
ABSTRACT
The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 states by early March. To uncover the sources of SARS-CoV-2 introductions and patterns of spread within the United States, we sequenced nine viral genomes from early reported COVID-19 patients in Connecticut. Our phylogenetic analysis places the majority of these genomes with viruses sequenced from Washington state. By coupling our genomic data with domestic and international travel patterns, we show that early SARS-CoV-2 transmission in Connecticut was likely driven by domestic introductions. Moreover, the risk of domestic importation to Connecticut exceeded that of international importation by mid-March regardless of our estimated effects of federal travel restrictions. This study provides evidence of widespread sustained transmission of SARS-CoV-2 within the United States and highlights the critical need for local surveillance.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Viaje / Infecciones por Coronavirus / Betacoronavirus Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Cell Año: 2020 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Viaje / Infecciones por Coronavirus / Betacoronavirus Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Cell Año: 2020 Tipo del documento: Artículo